Solutions with Henry Blodget cover art

Solutions with Henry Blodget

Solutions with Henry Blodget

By: Vox Media Podcast Network
Listen for free

Summary

We hear enough about our problems. Let’s solve them. Every Monday, journalist, analyst and entrepreneur Henry Blodget interviews leading thinkers across business, tech, politics and beyond about their big ideas for how to build a better future. Part of the Vox Media Podcast Network. Economics
Episodes
  • Are Psychedelics on the Verge of Going Mainstream?
    May 11 2026
    President Trump surprised many people a few weeks ago when he signed an executive order accelerating research into psychedelics. Compounds like psilocybin, LSD, MDMA, ketamine, and others have developed large and enthusiastic followings in the past decade, and some seem quite promising in the treatment of depression, PTSD, addiction and other conditions. Unusually, they are also one of the very few issues that have support across the political spectrum. This week, we discuss why this is a turning point for psychedelics and what might come next with Anne Philippi, a former journalist at Vogue, Vanity Fair, and GQ who now runs The New Health Club, a media organization dedicated to psychedelics. Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Show More Show Less
    40 mins
  • Why AI Will Never Be Conscious, According to a Consciousness Expert
    May 4 2026
    Anil Seth is concerned about the “mythology of conscious AI” – the growing argument that LLMs and other AI systems might one day achieve consciousness. Seth is a Professor of Cognitive and Computational Neuroscience at the University of Sussex and a leading expert on consciousness. He’s skeptical that AI will ever achieve true consciousness, and argues there’s danger in perceiving these technical systems as feeling beings. Today, we discuss that danger, and what science even defines as "consciousness." Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Show More Show Less
    1 hr and 7 mins
  • An Extraordinary Gene Editing Treatment Could Mark a Turning Point in Medicine
    Apr 27 2026
    In the summer of 2024, a baby named KJ was born with a rare disease with a 50% mortality rate. Six months later, he became the first patient to receive personalized gene editing therapy. He is now healthy and thriving. Dr. Jeff Coller, who directs the RNA Innovation Center at Johns Hopkins University, says KJ’s treatment could be the most important medical story of the decade. Today, Dr. Coller explains the ground-breaking science behind KJ’s treatment, and what it will take to bring it mainstream. Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Show More Show Less
    47 mins
adbl_web_anon_alc_button_suppression_c
No reviews yet